Unfortunately, medical treatments for Alzheimer’s disease and dementia have remained minimal for over 25 years, and with a ...

Vizamyl is now additionally indicated for use in a selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing information.

Formation of amyloid fibrils by Aβ42 protein is a pathological hallmark of Alzheimer’s disease. Aβ42 fibrillization is a nucleation-dependent polymerization process, in which nucleation is the ...

The US Food and Drug Administration (FDA) has granted approval for a label update to Eli Lilly and Company's Amyvid ...

In a surprising new discovery, scientists have found that newborn babies and patients with Alzheimer’s disease both have high ...

A collaborative team of researchers has succeeded in revealing the high-resolution structures of amyloid β (Aβ40) fibrils ...

A new study has revealed that newborn babies and Alzheimer’s patients both have elevated levels of the same protein, p-tau217 ...

For a long time, many researchers believed that a protein called amyloid-beta was the main cause. This protein builds up in ...

Dr. Nicholas Milano of Medical University of SC says medications such as Lecanemab and donanemab give Alzheimer's patients ...

Newborn babies and patients with Alzheimer's disease share an unexpected biological trait: elevated levels of a well-known ...

R136S, or the “Christchurch mutation,” appears to protect against Alzheimer’s disease by suppressing inflammatory signaling ...

Newborn babies and patients with Alzheimer's disease share an unexpected biological trait: elevated levels of a well-known ...